Serum levels of interleukin-18 in patients affected by allergic bronchial asthma

S. Gangemi, G. Lombardo, P. L. Minciullo, D. Bonanno, L. Giannetto, F. Guarneri, R. A. Merendino (Messina, Italy)

Source: Annual Congress 2002 - Cellular reactions in allergy in humans and animals
Session: Cellular reactions in allergy in humans and animals
Session type: Poster Discussion
Number: 309
Disease area: Airway diseases

Congress or journal article abstract

Abstract

Allergic asthma is a clinical condition associated with an evident Th2 imbalance.
IL-18, initially identified as a IFN-gamma-inducing factor, is a proinflammatory cytokine that plays an important role in Th1 cell activation. In contrast, recent studies demonstrate a role of this cytokine as inducer of atopic responses, including allergic asthma.
Aim of this study was to evaluate IL-18 serum levels in patients with moderate-severe asthma and, in addition, a possible correlation between this cytokine and FEV-1 into these patients.
To this end we enrolled 15 healthy nonatopic donors and 15 allergic patients with moderate-severe asthma no treated with oral parenteral or depot corticosteroids for, at least, 4 weeks prior to venipuncture.
IL-18 was essayed by immunoenzimatic method (Quantikine Human IL-18, R&S System, Milan, Italy). The detection limit for IL-18 was < 15 pg/mL.
Our data show that IL-18 serum levels were significantly (p<0,05) higher in asthmatic patients with respect to healthy donors (182,34 +/- 31,15 vs 104.36 +/- 20,19 pg/mL).
In addition a negative correlation between serum IL-18 levels and FEV-1 values (Rho= -0,624, p<0,01) was found.
At the light of these results, we think that IL-18 may be involved in induction of the allergic inflammation present in atopic asthma.
REFERENCES
1) Wild JS, Sigounas A, Sur N, Siddiqui MS, Alam R, Kurimoto M, Sur S.
IFN-gamma-inducing factor (Il-18) increases allergic sensitisation, serum IgE, Th2 cytokines and airway eosinophilia in a mouse model of allergic asthma.
J. Immunol 2000 Mar 1;164(5):2701-10.


Rating: 0
You must login to grade this presentation.

Share or cite this content

Citations should be made in the following way:
S. Gangemi, G. Lombardo, P. L. Minciullo, D. Bonanno, L. Giannetto, F. Guarneri, R. A. Merendino (Messina, Italy). Serum levels of interleukin-18 in patients affected by allergic bronchial asthma. Eur Respir J 2002; 20: Suppl. 38, 309

You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.

Member's Comments

No comment yet.
You must Login to comment this presentation.


Related content which might interest you:
Serum ECP levels do not correlate with degree of bronchial hyperresponsiveness in patients with cough variant asthma
Source: Eur Respir J 2005; 26: Suppl. 49, 584s
Year: 2005

Plasma eotaxin level in children with acute bronchial asthma
Source: Eur Respir J 2003; 22: Suppl. 45, 314s
Year: 2003

Elevated serum IL-12 and IL-18 levels in patients with bronchial asthma
Source: Eur Respir J 2002; 20: Suppl. 38, 424s
Year: 2002

Serum levels of IL-8, IL-10 and TNFα in severe allergic asthma
Source: Eur Respir J 2005; 26: Suppl. 49, 279s
Year: 2005

Serum and sputum interleukin-8: comparison between normal and allergic asthmatics children
Source: Eur Respir J 2003; 22: Suppl. 45, 175s
Year: 2003

Serum levels of interleukin-1α in patients affected by atopic and non atopic asthma
Source: Eur Respir J 2003; 22: Suppl. 45, 290s
Year: 2003

Elevated serum ECP in wheezing infants predicts the development of atopic asthma
Source: Eur Respir J 2002; 20: Suppl. 38, 192s
Year: 2002

Serum titres of cytokines show an imbalance in atopic asthma
Source: Eur Respir J 2004; 24: Suppl. 48, 351s
Year: 2004

Serum eotaxin level in male with allergic diseases
Source: Eur Respir J 2002; 20: Suppl. 38, 311s
Year: 2002

Serum eosinophil cationic protein as a marker of disease severity in patients with bronchial asthma
Source: Eur Respir J 2001; 18: Suppl. 33, 51s
Year: 2001

Serum TNF-a, IL-12 and IL-13 levels in severe bronchial asthma patients
Source: Eur Respir J 2004; 24: Suppl. 48, 353s
Year: 2004

Interaction between eotaxin and IL-13 in serum and sputum: comparison between normal and allergic asthmatic children
Source: Eur Respir J 2004; 24: Suppl. 48, 396s
Year: 2004

Cytokine plasma levels in moderate-to-severe asthmatic children with different asthma control
Source: Virtual Congress 2020 – Phenotypes of asthma and COPD
Year: 2020


Zinc in serum and induced sputum of patients with allergic rhinitis and allergic asthma
Source: Eur Respir J 2004; 24: Suppl. 48, 353s
Year: 2004

Eotaxin in serum and sputum: comparison between normal and allergic asthmatic children
Source: Eur Respir J 2004; 24: Suppl. 48, 163s
Year: 2004

Iron in serum and induced sputum of patients with allergic rhinitis and allergic asthma
Source: Eur Respir J 2006; 28: Suppl. 50, 445s
Year: 2006

Plasma leukotriene level in atopic and non-atopic asthmatic children and its correlation to severity of the disease
Source: Eur Respir J 2003; 22: Suppl. 45, 314s
Year: 2003

Pulmonary function and levels of serum leptin and interleukin-6 in women with bronchial asthma
Source: International Congress 2018 – Does asthma phenotyping improve treatment?
Year: 2018




Inhibiting effect of influenza vaccinations on serum eotaxin level in patients with allergic bronchial asthma and chronic obstructive pulmonary disease
Source: Eur Respir J 2004; 24: Suppl. 48, 134s
Year: 2004

Inflammatory cytokines in serum from children with severe asthma compared to controlled asthmatics
Source: Annual Congress 2012 - Mechanisms and risk of childhood asthma and allergy
Year: 2012